Toggle navigation
History
Approach
Team
Companies
News Room
Contact
Celgene to acquire Impact Biomedicines, adding Fedratinib to its pipeline of novel therapies for hematologic malignancies
Press Release
Everyone Goes Home with a Balloon - Impact Biomedicines
Blog
Medicxi unveils ‘The Foundation Institute’
Press Release
The Making of Medicxi: We have the Operating Partner
Blog
